1/22
12:01 am
arvn
New nanoparticle technology offers hope for hard-to-treat diseases [Yahoo! Finance]
Low
Report
New nanoparticle technology offers hope for hard-to-treat diseases [Yahoo! Finance]
1/12
06:12 am
arvn
Here's Why We're Not Too Worried About Arvinas' (NASDAQ:ARVN) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Not Too Worried About Arvinas' (NASDAQ:ARVN) Cash Burn Situation [Yahoo! Finance]
1/6
07:07 am
arvn
Arvinas (NASDAQ:ARVN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Low
Report
Arvinas (NASDAQ:ARVN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
12/17
07:05 am
arvn
Arvinas (NASDAQ:ARVN) was given a new $18.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Low
Report
Arvinas (NASDAQ:ARVN) was given a new $18.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
12/11
07:14 am
arvn
How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating [Yahoo! Finance]
Medium
Report
How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating [Yahoo! Finance]
12/11
04:14 am
arvn
Arvinas (NASDAQ:ARVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Arvinas (NASDAQ:ARVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/6
08:05 am
arvn
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
Medium
Report
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
11/26
07:15 am
arvn
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/26
07:00 am
arvn
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference
Low
Report
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference
11/24
07:00 am
arvn
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
Low
Report
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
11/18
12:30 am
arvn
Revisiting the Narrative for Arvinas as Analyst Views Shift with New Pipeline and Partner Risks [Yahoo! Finance]
High
Report
Revisiting the Narrative for Arvinas as Analyst Views Shift with New Pipeline and Partner Risks [Yahoo! Finance]